Printer's No. PN1187
See other bills
under the
same topic PRINTER'S NO. 1187 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.158 Session of 2025 INTRODUCED BY HANBIDGE, FREEMAN, KHAN, VENKAT, McNEILL, HILL-EVANS, SANCHEZ, GIRAL, MADDEN, WAXMAN, MAYES, CEPHAS, CERRATO, CEPEDA-FREYTIZ, HOWARD, D. WILLIAMS, HOHENSTEIN, STEELE, O'MARA, SHUSTERMAN AND GREEN, MARCH 31, 2025 REFERRED TO COMMITTEE ON HEALTH, MARCH 31, 2025 A RESOLUTIONDesignating the month of May 2025 as "Preeclampsia Awareness Month" in Pennsylvania.WHEREAS, Preeclampsia is a dangerous complication of pregnancy that is associated with a rapid rise in blood pressure that can lead to a variety of negative health outcomes, including seizures, strokes and organ failure, among other conditions; andWHEREAS, Preeclampsia generally occurs after the 20th week of pregnancy, but in rare cases, the condition can develop after the mother gives birth, which demands immediate treatment; andWHEREAS, In the most severe cases, preeclampsia can lead to the death of the mother or the infant, in addition to premature birth, which also presents significant, long-term health risks for the mother and child; andWHEREAS, Preeclampsia is estimated to occur in 2% to 8% of all pregnancies and is one of the leading causes of death due to pregnancy; and1234567891011121314151617 WHEREAS, A pregnant individual is at a higher risk of preeclampsia if the individual is undergoing a first pregnancy, is over 40 years of age, has experienced a large interval since her last pregnancy, has had preeclampsia during a previous pregnancy or has a history of hypertension, chronic kidney disease or diabetes, among other conditions; andWHEREAS, HELLP syndrome is a variant of preeclampsia named for its characteristics of hemolysis, elevated liver enzymes and low platelet count; andWHEREAS, The conditions of HELLP syndrome may develop without any prior symptoms, are life-threatening to both the mother and infant and may present lifelong health complications for the mother; andWHEREAS, If not properly recognized and managed, preeclampsia can progress to eclampsia, which can cause pregnancy-related seizures or comas, although eclampsia can develop without any observed symptoms of preeclampsia; andWHEREAS, Public education on signs and symptoms of preeclampsia, HELLP syndrome and eclampsia can help those who are pregnant recognize these threatening conditions and seek appropriate medical care; andWHEREAS, Prenatal education should incorporate recognition of symptoms, including spikes in maternal blood pressure, sudden swelling of face and hands, severe upper abdominal pain, blurred vision, persistent headaches and breathlessness; andWHEREAS, Many residents of this Commonwealth have joined with the Preeclampsia Foundation to raise public awareness in keeping with the goal of minimizing maternal and infant illness and death due to preeclampsia; andWHEREAS, The House of Representatives supports the 20250HR0158PN1187 - 2 - 123456789101112131415161718192021222324252627282930 Preeclampsia Foundation in its efforts to provide support and improve health care practices for individuals impacted by preeclampsia and related hypertensive disorders of pregnancy; therefore be itRESOLVED, That the House of Representatives designate the month of May 2025 as "Preeclampsia Awareness Month" in Pennsylvania.20250HR0158PN1187 - 3 - 1234567
under the
same topic PRINTER'S NO. 1187 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.158 Session of 2025 INTRODUCED BY HANBIDGE, FREEMAN, KHAN, VENKAT, McNEILL, HILL-EVANS, SANCHEZ, GIRAL, MADDEN, WAXMAN, MAYES, CEPHAS, CERRATO, CEPEDA-FREYTIZ, HOWARD, D. WILLIAMS, HOHENSTEIN, STEELE, O'MARA, SHUSTERMAN AND GREEN, MARCH 31, 2025 REFERRED TO COMMITTEE ON HEALTH, MARCH 31, 2025 A RESOLUTIONDesignating the month of May 2025 as "Preeclampsia Awareness Month" in Pennsylvania.WHEREAS, Preeclampsia is a dangerous complication of pregnancy that is associated with a rapid rise in blood pressure that can lead to a variety of negative health outcomes, including seizures, strokes and organ failure, among other conditions; andWHEREAS, Preeclampsia generally occurs after the 20th week of pregnancy, but in rare cases, the condition can develop after the mother gives birth, which demands immediate treatment; andWHEREAS, In the most severe cases, preeclampsia can lead to the death of the mother or the infant, in addition to premature birth, which also presents significant, long-term health risks for the mother and child; andWHEREAS, Preeclampsia is estimated to occur in 2% to 8% of all pregnancies and is one of the leading causes of death due to pregnancy; and1234567891011121314151617 WHEREAS, A pregnant individual is at a higher risk of preeclampsia if the individual is undergoing a first pregnancy, is over 40 years of age, has experienced a large interval since her last pregnancy, has had preeclampsia during a previous pregnancy or has a history of hypertension, chronic kidney disease or diabetes, among other conditions; andWHEREAS, HELLP syndrome is a variant of preeclampsia named for its characteristics of hemolysis, elevated liver enzymes and low platelet count; andWHEREAS, The conditions of HELLP syndrome may develop without any prior symptoms, are life-threatening to both the mother and infant and may present lifelong health complications for the mother; andWHEREAS, If not properly recognized and managed, preeclampsia can progress to eclampsia, which can cause pregnancy-related seizures or comas, although eclampsia can develop without any observed symptoms of preeclampsia; andWHEREAS, Public education on signs and symptoms of preeclampsia, HELLP syndrome and eclampsia can help those who are pregnant recognize these threatening conditions and seek appropriate medical care; andWHEREAS, Prenatal education should incorporate recognition of symptoms, including spikes in maternal blood pressure, sudden swelling of face and hands, severe upper abdominal pain, blurred vision, persistent headaches and breathlessness; andWHEREAS, Many residents of this Commonwealth have joined with the Preeclampsia Foundation to raise public awareness in keeping with the goal of minimizing maternal and infant illness and death due to preeclampsia; andWHEREAS, The House of Representatives supports the 20250HR0158PN1187 - 2 - 123456789101112131415161718192021222324252627282930 Preeclampsia Foundation in its efforts to provide support and improve health care practices for individuals impacted by preeclampsia and related hypertensive disorders of pregnancy; therefore be itRESOLVED, That the House of Representatives designate the month of May 2025 as "Preeclampsia Awareness Month" in Pennsylvania.20250HR0158PN1187 - 3 - 1234567
Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.